Antiviral good medicine --- tenofovir
Tenofovir has been approved for listing, in fact, many patients already taking this medicine. Foreign listed in 2008, Luo anti-predecessors have used this medicine for nearly 3 years, an estimated 400 people. Interaction from the thread can be roughly peep hepatitis B treatment situation, the recent reduction in the number of patients entecavir taken soared. It is expected that after 2 years of tenofovir drug costs will also be reduced (because the patent medicine is about to expire, and the domestic generic drugs will come out, the price of generic drugs will drop greatly) and the first-line drugs in China will also become the mainstream drug for hepatitis B antiviral therapy, Many patients with second-line nucleoside drug efficacy is not high drug-resistant distress will gradually fade away.
Luo anti-old predecessors engaged in hepatitis B clinical and research more than half a century, the first drug only yeast tablets, and then diphenyl ester double enzyme, so deal with more than 30 years, it is helpless. 1990 with ordinary interferon, with lamivudine in 2000, 04 years Pegasus (long-acting interferon) listed in 2005 adefovir, 06 entecavir clinical application, and now for the new Norfolk Wei, China's health insurance is developing, the lack of money and less hepatitis B patients are changing. As an old doctor, I feel very excited to be able to use such a good medicine for the rest of my life, doubling her ability to treat.
This also illustrates the truth that it seems that physicians' energy has dropped significantly without drugs.